We are live on ! Find out more
LABS

Direxion Daily S&P Biotech Bear 1X Shares
LABS

Delisted

LABS was delisted on the 25th of September, 2017.

Back to rankings

2 hedge funds and large institutions have $1.44M invested in Direxion Daily S&P Biotech Bear 1X Shares in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

34% less capital invested

Capital invested by funds: $2.19M → $1.44M (-$746K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$1.92M
2
Jane Street
Jane Street
New York
-$24.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$1.23M +$1.33M +38,402 New
Jane Street
2
Jane Street
New York
$210K -$24.1K -699 -10%
Citigroup
3
Citigroup
New York
– -$1.92M -49,900 Closed

LABS Hedge Fund Activity: Q1 2017 in Review

2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 1X Shares (LABS) for Q1 2017, worth a combined $1.44M — down 34% from $2.19M a quarter earlier.

Fund positioning in LABS was balanced in Q1 2017: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $1.33M. The largest seller was Citigroup, exiting entirely with an estimated $1.92M sold.

  • 2 institutional investors held Direxion Daily S&P Biotech Bear 1X Shares (LABS) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $1.44M of Direxion Daily S&P Biotech Bear 1X Shares stock for Q1 2017, down 34% quarter-over-quarter.
  • 1 fund opened new Direxion Daily S&P Biotech Bear 1X Shares positions in Q1 2017 and 1 closed out, a net change of 0 holders.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares buyer in Q1 2017 was Virtu Financial, an estimated $1.33M added.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares seller in Q1 2017 was Citigroup, an estimated $1.92M sold.

Based on aggregated 13F filings for Q1 2017.